Cardiac Electrophysiological Impact of Sodium Glucose Cotransporter 2 Inhibitors: A Comprehensive Review.
Listen to this summary
This review asks whether SGLT2 inhibitors, beyond their glycemic and heart failure benefits, meaningfully affect cardiac autonomic function, arrhythmia risk, and related microRNA signaling. The authors synthesize clinical trials, meta-analyses, and preclinical studies, finding evidence of sympathoinhibition, modest reductions in atrial fibrillation/flutter and possibly sudden cardiac death, and anti-arrhythmic mechanisms such as NHE and late sodium current inhibition. They also report that SGLT2 inhibitors modulate microRNAs (e.g., miR-21, miR-29, miR-30, miR-34a, miR-92) that may underlie these effects, but they conclude that dedicated trials are needed to establish causality and dose-dependence.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Circulation. Arrhythmia and electrophysiology
View all →Nov 20, 2026 · Circulation. Arrhythmia and electrophysiology
Dynamic Risk Assessment of Severe Ventricular Arrhythmia in Patients With Implantable Defibrillators and Reduced Left Ventricular Ejection Fraction.
Nov 19, 2026 · Circulation. Arrhythmia and electrophysiology
Incidence, Risk Factors and Natural History of Atrial Arrhythmias in Patients With Systemic Right Ventricle.
Nov 18, 2026 · Circulation. Arrhythmia and electrophysiology
Myocardial Hmgcs2-Driven Ketogenesis Promotes Atrial Fibrillation in Diabetes.
Oct 12, 2026 · Circulation. Arrhythmia and electrophysiology
Multichannel Dysfunction Associated With a Dominant-Negative KCNH2 Missense Variant, p.G604S, Results in Action Potential Duration Prolongation and Early Afterdepolarizations in a Patient-Specific, Reengineered Cardiomyocyte Model of Type 2 Long-QT Syndrome.
Oct 8, 2026 · Circulation. Arrhythmia and electrophysiology
Value of Left Ventricular Low Voltage Area and Ejection Fraction in Predicting End-Stage Heart Failure Outcomes After Ventricular Tachycardia Ablation in Patients With Non-Ischemic Cardiomyopathy.
Oct 8, 2026 · Circulation. Arrhythmia and electrophysiology
Serial Artificial Intelligence ECG-Derived Atrial Fibrillation Probability and Recurrence Risk After Pulsed Field Ablation.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


